When analyzing small stress proteins of rat and human tissues by electrophoretic methods followed by western blotting, and using the anti-HspB1/anti-HspB5 antibody clone 8A7, we unexpectedly found a protein with a molecular mass of~44 kDa. On two-dimensional gels, this protein resolved into four distinct species. Electrophoretic and immunological evidence suggests that this 44 kDa protein is a derivative of HspB5, most likely a covalently linked HspB5 dimer. This HspB5-like 44 kDa protein (HspB5L-P44) is particularly abundant in rat heart, brain, and renal cortex and glomeruli. HspB5L-P44 was also found in human brains, including those from patients with Alexander disease, a condition distinguished by cerebral accumulation of HspB5. Gray matter of such a patient contained an elevated amount of HspB5L-P44. A spatial model of structurally ordered dimeric HspB5 α-crystallin domains reveals the exposed and adjacent position of the two peptide segments homologous to the HspB1-derived 8A7 antigen determinant peptide (epitope). This explains the observed extraordinary high avidity of the 8A7 antibody towards HspB5L-P44, as opposed to commonly used HspB5-specific antibodies which recognize other epitopes. This scenario also explains the remarkable fact that no previous study reported the existence of HspB5L-P44 species. Exposure of rat endothelial cells to UV light, an oxidative stress condition, temporarily increased HspB5L-P44, suggesting physiological regulation of the dimerization. The existence of HspB5L-P44 supports the protein speciation discourse and fits to the concept of the protein code, according to which the expression of a given gene is reflected only by the complete set of the derived protein species.
Introduction
Mammalian genomes encode ten small heat shock proteins (sHSP), now systematically named HspB1 through HspB10 (Kampinga et al. 2009 ). sHSPs are defined by a highly conserved~85 amino acid residue sequence element called α-crystallin domain which is typically encompassed by a less conserved N-terminal domain and a poorly conserved and highly flexible region of Cterminal extensions (Fontaine et al. 2003; Benndorf et al. 2014) . In humans and rats, HspB5 (αB-crystallin) is encoded by the CRYAB and Cryab gene, respectively. HspB5, together with the related HspB4, was discovered in the lens of the eye more than a century ago and belongs historically to the first proteins to be known (Mörner 1893) . Today, we know that HspB5 occurs in many organs and tissues at Bbaseline^conditions (Lowe et al. 1992a; Klemenz et al. 1993) , in some cases in extraordinary high amounts (Kato et al. 1991) , and its synthesis can be further induced by a number of stress conditions, including oxidative stress and various neuropathologies (Klemenz et al. 1991; Iwaki et al. 1992 Iwaki et al. , 1993 Renkawek et al. 1992; Lowe et al. 1992a Lowe et al. , 1992b . At the molecular level, the best studied functions of HspB5 include its chaperone-like activity and its role in the organization of the cytoskeleton, notably the intermediate filaments (Mymrikov et al. 2011; Elliott et al. 2013; Haslbeck et al. 2016) . The CRYAB gene is affected in humans by a number of mutations that result in various myopathies and in the formation of cataracts in the lens of the eye (Benndorf 2010; Datskevich et al. 2012; Benndorf et al. 2014) .
Like most if not all sHSPs, HspB5 forms dimers and oligomeric complexes of variable size, be they homologous or heterologous dimers or oligomeric complexes with other sHSPs (Mymrikov et al. 2011 ). This quaternary structure of sHSPs has been extensively studied (Behlke et al. 1995; Bagnéris et al. 2009; Jehle et al. 2010; Aquilina et al. 2013; Delbecq et al. 2015) , and it is thought that dimers are the basic building block of such oligomeric sHSPs. For HspB5, all naturally occurring dimers and oligomeric complexes reported to date are formed by association without involvement of a covalent bond as they can be dissociated by breaking the hydrophobic and hydrogen bonds with detergents and urea, respectively, such as applied during electrophoretic procedures. Covalently bonded dimers have been found only after chemical oxidation of mixed populations of HspB5 and HspB4 (Balasubramanian and Kanwar 2002; Shum et al. 2005) . Apart from those studies, we could not find any other reports on covalently bonded HspB5 dimers.
In the past decade, it became clear that commonly determined gene expression often falls short in terms of understanding the functions of a given protein in live cells (Jungblut et al. 2016) . Instead, the entirety of the derived forms of a protein (protein species 1 ) seems critical for its function. These protein species are generated by various modifications, splicing, and/or truncations, eventually resulting in a tremendous diversification of a given protein. This development has opened a whole new world Bbelow^the level of the proteins, and the resulting protein speciation discourse has led to the concept of the protein code. Examples include the diversity of the histones (Jungblut et al. 2016) , but also of HspB1 of which at least 59 and 15 species have been found in the human heart and in murine Ehrlich ascites tumor cells, respectively (Benndorf et al. 1992; Scheler et al. 1997; Benndorf and Jungblut 2015) . Conceptually, we distinguish between commonly observed (canonical) and rarely or newly observed (non-canonical) protein species.
Here we report a novel 44 kDa protein which is, according to electrophoretic and immunological evidence, related to HspB5 and most likely a covalently linked HspB5 dimer. This protein occurs in a number of rat tissues, and also in healthy and diseased human brains, with the latter known to accumulate abnormal amounts of HspB5. The discovery of this protein was by chance when we studied the sHSP expression in rat tissues using the monoclonal anti-HspB1-/HspB5-specific antibody clone 8A7 which was raised against a short peptide derived from the α-crystallin domain of human HspB1. This antibody exhibits an extraordinary high avidity towards this HspB5-related 44 kDa protein, as compared to the canonical HspB5 species, and as compared to an HspB5-specific antibody which was raised against a peptide derived from the Cterminal extension of human HspB5. Analyzing the positions of the epitopes for both antibodies in spatial models of HspB5, we provide a rationale for the observed high avidity of the 8A7 antibody towards this novel HspB5-derived protein, and also for the remarkable fact that this protein was not noticed in the numerous earlier studies on HspB5. Our findings on this novel HspB5 species further support the protein speciation discourse and fit with the concept of the protein code.
1 According to the IUPAC-IUBMB Joint Commission on Biochemical Nomenclature rules (Nomenclature of multiple forms of enzymes. In: Biochemical nomenclature and related documents, 2nd edition. Edited by: Liébecq C. Colchester; Portland press; 1992), we refer to differentially modified protein forms as Bprotein species,^as we have justified before (Benndorf and Jungblut 2015) . The term isoform should be restricted to genetic variants. We refer to newly observed or rare protein species as Bnon-canonical protein species^which are typically found in non-canonical spots on two-dimensional gels, as opposed to the Bcanonical protein species^which designates the traditionally observed protein species that are found in the canonical spots on two-dimensional gels. It should also be noted that a single protein spot on two-dimensional gels may contain more than one protein species ).
Methods

Human patients
We examined frozen tissues of the central nervous system (CNS), including isocortex and subcortical white matter, taken at autopsy from three patients with genetically caused Alexander disease (AXD): a 7-year-old male and an 8-year-old female with an R416W GFAP mutation each, and a 9-year-old female with an R239C GFAP mutation. For control purposes, we examined CNS tissues from a 2-year-old female with no neuropathology and from an 8-year-old male with X-linked adrenoleukodystrophy (ALD). All AXD patients showed the typical loss of myelin in white matter with many astrocytes with Rosenthal fibers, and many subpial astrocytes with Rosenthal fibers. The patient with ALD also showed loss of myelin and astrocytic gliosis in white matter, but no Rosenthal fibers.
Tissue sampling and extraction procedures
Tissues were harvested from two male Wistar rats of 200 g weight, washed in saline, and snap frozen in liquid nitrogen. Renal cortex, medulla, and glomeruli were prepared as described previously (Smoyer et al. 2000; Guess et al. 2010) . Approximately 40,000 renal glomeruli were isolated from two kidneys under semisterile conditions, and the preparation was assessed by microscopic inspection and contained~95% glomeruli. Protein extraction was essentially as described earlier (Guess et al. 2013) . In brief, tissues were homogenized at 4°C in tissue protein extraction reagent T-PER (Pierce, Rockford, Illinois) in the presence of protease inhibitors (Sigma-Aldrich, St. Louis, Missouri) at 20 ml per gram tissue, using a Dounce homogenizer. Lysates were centrifuged at 14,000g for 5 min, and aliquots of the supernatant were stored at − 80°C. For twodimensional polyacrylamide gel electrophoresis (2D-PAGE), homogenates were adjusted to 6 M urea, 2% ampholytes 3-10, 2% Triton X-100, and 10 mM dithiothreitol (final concentrations), containing 3.3 mg/ml total protein. For SDS-polyacrylamide gel electrophoresis (SDS-PAGE), homogenates were mixed with 5 × SDS sample buffer, yielding a final concentration of 1.0 mg/ ml total protein in 62.5 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol, 5% β-mercaptoethanol, and 0.05% bromophenol blue. Before loading, the SDS samples were heated for 4 min in a water bath at 100°C. Saline-washed and snap frozen human brain samples were processed for SDS-PAGE like the rat tissues.
Endothelial cell culture 4 × 10 5 rat pulmonary arterial endothelial cells (passages 10 to 16) were plated into each well of 6-well plates and grown in a 1:1 mix of Ham's F12:Dulbecco's Modified Eagle Medium (GibcoBRL, Grand Island, New York) supplemented with 5% fetal calf serum, 50 μg/ml penicillin, and 50 μg/ml streptomycin, for 96 h in a humidified atmosphere of 5% CO 2 at 37°C prior to the assay (Gilmont et al. 1996; Hirano et al. 2004) . For ultraviolet (UV) light exposures, the plates were placed without lid for 30 min in a biosafety cabinet under a UV lamp at an energy density of 2 4 0 μ W / c m 2 ( m a n u f a c t u r e r 's s p e c i f i c a t i o n ) . Thereafter, the cells were returned to the incubator and allowed to recover for up to 24 h. At the indicated time points, the culture medium was aspirated and cells were washed twice with PBS, detached from the support with a cell scraper, and collected by centrifugation. Cells were lysed by adding 200 μl tissue protein extraction reagent and processed for SDS-PAGE as described above.
Electrophoretic methods
2D-PAGE was conducted using the Multiphor II Electrophoresis System from Amersham Biosciences (GE Healthcare, Uppsala, Sweden) with Immobiline dry strips (3-10) for separation of the proteins by their isoelectric points (pI) in the first dimension. Subsequently, these strips were mounted onto the slab gels containing 0.1% SDS for the separation of the proteins according to their relative molecular masses (Mr). For SDS-PAGE, 30 μg total protein (unless specified otherwise) was loaded onto 10% polyacrylamide gels according to standard procedures. After the run, the proteins were electrotransferred onto polyvinylidene difluoride (PVDF) membranes for immunolabeling (western blotting). The apparent molecular masses and isoelectric points were estimated by using reference proteins. Purified HspB5 was purchased from StressGen Biotechnologies, Victoria, British Columbia. The entire procedures were described in detail elsewhere .
The relative amounts of 8A7-reactive proteins in the various rat tissues were semi-quantitatively estimated by densitometry of the corresponding protein bands as obtained by western blotting. Developed X-ray films were scanned into files using a GS 200 Imaging Densitometer (Bio-Rad, Hercules, California) controlled by the accompanying software and using standard settings. The densitometric analysis was performed using the ImageJ program (version 1.46r) which is available at http://rsb. info.nih.gov/ij/. The signal intensity obtained for the putative HspB5 dimer (HspB5-L-P44) was related to the signal intensity obtained for monomeric HspB5 in the same sample, and expressed as a ratio. Comparison of these numeric values from different tissues is informative with respect to the relative ratios; however, these values do not allow any conclusion about the absolute amounts of the corresponding proteins in the samples.
Antibodies
The mouse monoclonal anti-HspB1/anti-HspB5 antibody clone 8A7 was obtained from StressMarq Biosciences Inc., Victoria, British Columbia (catalog no. SMC-114). This antibody was raised against the epitope peptide KHEERQDEHGYISRC derived from human HspB1 (positions 123-137) (Bitar et al. 1991; Jia et al. 2001) , herein referred to as the 8A7 antigen determinant peptide (8A7-ADP). Because this selected 8A7-ADP sequence is evolutionarily highly conserved, the 8A7 antibody cross-reacts also with the homologous 8A7-ADPs (ho-ADP) of HspB1 and HspB5 of a number of other mammalian species (including rats), albeit partially with reduced intensity.
The used HspB5-specific rabbit polyclonal anti-HspB5 antibody was kindly provided by Dr. J. Horwitz, The Jules Stein Eye Institute, University of California Los Angeles, Los Angeles, California. This antibody was raised against the epitope peptide REEKPAVTAAPKK which represents the uttermost C-terminal end of human HspB5, herein referred to as anti-HspB5 antigen determinant peptide (aB5-ADP) (Bhat et al. 1991) . Based on the strong sequence similarity among mammalian HspB5 (Benndorf et al. 2014) , this antibody reacts also with HspB5 of other species, including rats.
Secondary antibody solutions contained either peroxidaseconjugated goat anti-rabbit (dilution 1:10,000) or goat antimouse (dilution 1:10,000) antibodies, both from Jackson ImmunoResearch Laboratories (West Grove, Pennsylvania). Antibody binding was visualized with the ECL chemiluminescence system from GE Healthcare Bio-Sciences (Piscataway, New Jersey) and detected by exposure to X-ray film.
2D-PAGE database search
Among the numerous developed 2D-PAGE databases, only a few are still accessible today, including the World 2D-PAGE database (http://world-2dpage.expasy.org/swiss-2dpage), the 2D-PAGE database at MPIIB (http://www.mpiib-berlin.mpg. de/2D-PAGE/), the Reproduction 2D-PAGE database (http:// reprod.njmu.edu.cn/), and the UCD 2D-PAGE database (http://proteomics-portal.ucd.ie/). These databases were queried using the keywords alphaB crystallin and CryAB, as well as the accession numbers P23927 and P02511 for mouse and human HspB5, respectively.
GenBank accessions
Human HspB5, NP_001876 (P02511); rat HspB5, NP_037067 (P23928); human HspB1, NP_001531 (P04792); rat HspB1, NP_114176 (P42930); mouse HspB5, NP_001276714 (P23927)
Results
Immunological and electrophoretic evidence for the existence of novel 44 kDa protein species related to HspB5 in rat tissues Using 2D-PAGE followed by western blotting, we analyzed rat tissues for the occurrence of HspB1 and HspB5. For that purpose, we applied the monoclonal anti-HspB1/anti-HspB5 antibody clone 8A7 which was raised against the human HspB1-derived 8A7-ADP and which cross-reacts also with the ho-ADP sequences in rat HspB1 and rat HspB5 (cf. Methods section). As expected, in rat hearts, the 8A7 antibody detected the three canonical HspB1 spots at a Mr of~25 kDa (spot 1: pI~6.1, spot 2: pI~5.8, spot 3: pI~5.6), corresponding to non-phosphorylated, singly phosphorylated, and doubly phosphorylated HspB1 species, respectively. At a Mr of~22 kDa, the 8A7 antibody detected a single HspB5 spot (pI~6.8), corresponding to the canonical non-modified monomeric HspB5 species (Fig. 1) . Similarly, in rat brains, this antibody labeled HspB1 which appeared only in spot 3, and non-modified monomeric HspB5.
Surprisingly, in both tissues, the 8A7 antibody strongly labeled additional protein species in the Mr range of 44 kDa, appearing in four spots (spot 1: pI~6.8, spot 2: pI~6.6, spot 3: pI~6.5, spot 4: pI~5.0) in the heart, and mainly in one spot (spot 3: pI~6.5) in the brain, with only faint labeling of spots 1 and 2 (Fig. 1) . Additionally, in the brain, this antibody labeled a smear that Bconnects^the monomeric HspB5 spot with spot 1 of the 44 kDa protein, including a few discrete Bintermediate protein species^(indicated by the bracket in Fig. 1 ).
For comparison, the same samples were analyzed by 2D-PAGE/western blotting using an antibody that is highly specific for HspB5 (cf. Methods section). As expected, this antibody labeled non-modified monomeric HspB5 at a Mr of 22 kDa (pI~6.8) in both tissues, but none of the HspB1 species (Fig. 1 ). However, a closer inspection revealed that in rat hearts, this antibody labeled also the most abundant species of the 44 kDa protein in spot 1, albeit only slightly.
Together these findings suggest that the 44 kDa protein is related to HspB5, and most likely it is an HspB5 dimer. The arguments are the following: (i) The strong labeling by the 8A7 antibody implies that it contains the 8A7-ADP, or a closely related (homologous) sequence which must originate from an sHSP; (ii) The 44 kDa protein is also recognized, although weakly, by the highly specific anti-HspB5 antibody; (iii) The most abundant protein species in the heart in spot 1 has the same pI of~6.8 as the non-modified monomeric HspB5; (iv) The 44 kDa protein species have approximately twice the Mr compared to monomeric HspB5; and (v) The Bconnecting smear^seen in the brain sample. In the past, we have repeatedly observed such connecting smears on 2D-PAGE gels and blots between related protein species. An informative example is the smear that connects the HspB1 species contained in several spots on a two-dimensional gel (Benndorf and Jungblut 2015) . Accordingly, the connecting smear shown in Fig. 1 suggests that the 44 kDa protein indeed is related to HspB5.
Since we could not find any earlier study reporting this protein in mammalian tissues, we termed it BHspB5-like 44 kDa protein^(HspB5L-P44), existing in at least four species which differ in their isoelectric points.
HspB5 is known to assemble into dimers and oligomeric complexes (cf. Introduction), and the presence of HspB5 dimers can be expected in physiological conditions in tissues. However, these dimers should completely dissociate into monomers in the presence of 6 M urea, 2% Triton-X100, 10 mM dithiothreitol, and 0.1% SDS during the sampling and electrophoretic procedures of the 2D-PAGE, resulting solely in the appearance of monomeric HspB5 on western blots of two-dimensional gels. The fact that HspB5L-P44 endured these procedures strongly suggests that this protein is formed by a covalent bond between the two HspB5 monomers, and not just by association, and thus represents a novel HspB5-like protein.
Figure 1 also implies that the 8A7 antibody is distinguished by its high affinity towards HspB5L-P44, as opposed to the HspB5-specific antibody which hardly recognized just the most abundant HspB5L-P44 species. Thus, the 8A7 antibody is a suitable tool for analyzing mammalian tissues for the presence of HspB5L-P44.
Subsequently, a larger number of rat tissues were analyzed by SDS-PAGE followed by western blotting for the presence of both HspB5L-P44 and HspB5 species, using the 8A7 antibody (Fig. 2) . Confirming earlier results collected in rodents and humans (Dubin et al. 1989; Iwaki et al. 1992; Renkawek et al. 1992; Klemenz et al. 1993; Lutsch et al. 1997; Smoyer et al. 2000; van de Bovenkamp et al. 2006 ), strong to moderate signals for HspB5 were obtained in the lens of the eye, heart, skin, and spleen and in the renal compartments including cortex, glomeruli, and especially the medulla, whereas the lung, brain, and liver contained minor yet detectable amounts of HspB5.
The 8A7 antibody produced strong or moderate signals for HspB5L-P44 in the heart, lung, brain, renal cortex, and renal glomeruli, and faint signals in the eye lens, testis, liver, and skin, and also in commercially available HspB5 (Fig. 2) . Interestingly, renal medulla which contains extraordinary high amounts of HspB5 (Smoyer et al. 2000) contains hardly any HspB5L-P44, which distinguishes this from the other renal compartments, the cortex and glomeruli. Apparently, HspB5L-P44 occurs in a number of rat tissues, albeit in different amounts.
The processing of these samples for the SDS-PAGE included a boiling step at 100°C for 4 min in the presence of 2.0% SDS and 5% β-mercaptoethanol. The fact that the HspB5L-P44 endured also this harsh denaturing condition provides further and strong evidence that this HspB5 dimer is formed by a covalent bond. Fig. 1 Immunologic and 2D-PAGE evidence for an HspB5-related 44 kDa protein (HspB5L-P44) in rat heart and brain. The western blots were stained either with the 8A7 antibody (recognizes HspB5 and HspB1) or with the HspB5-specific antibody, as indicated. The positions of pI and Mr standard proteins are marked. The Bconnecting smear^between the spots of monomeric HspB5 and of HspB5L-P44 in the brain sample, labeled by the 8A7 antibody, is indicated by the bracket Although the affinities of the 8A7 antibody for both HspB5L-P44 and HspB5 are not known and can be assumed to differ greatly, Fig. 2 permits the conclusion that the relative amounts of HspB5L-P44 and HspB5 in the various tissues do not correlate. In the testis and brain, the HspB5L-P44 signals prevail, whereas in the eye lens, skin, spleen, and renal medulla, the HspB5 signals prevail. In the heart, lung, liver, renal cortex, and renal glomeruli, both signals exhibit a similar intensity. A semi-quantitative evaluation of the relative band densities confirms this notion of different relative HspB5L-P44/HspB5 ratios in the studied tissues, varying between < 0.05 and > 10. The numeric values for each studied tissue are given in Fig. 2 .
As anticipated from literature data (Tanguay et al. 1993; Klemenz et al. 1993) , the 8A7 antibody labeled also HspB1 in a number of these tissues (Fig. 2) , that is, however, of little relevance to this report.
HspB5L-P44 in human brains
In order to verify the existence of HspB5L-P44 in human tissues, we analyzed CNS tissues taken at autopsy from three patients with infantile AXD with defined missense mutations in the GFAP gene (cf. Methods section). For control purposes, CNS tissues were taken from one patient each with no neuropathology (C1) and with X-linked ALD (C2). Human brain is known to contain HspB5 (Iwaki et al. 1992; Renkawek et al. 1992) , the amount of which can be greatly increased in a number of neurological disorders (Iwaki et al. 1992; Renkawek et al. 1992; Lowe et al. 1992a, b) , including AXD which is characterized by the deposition of HspB5-containing Rosenthal fibers in astrocytes (Iwaki et al. 1989; Head et al. 1993) . All three AXD patients included in this study showed the typical loss of myelin in white matter with many astrocytes with Rosenthal fibers, as opposed to the control patients which had no Rosenthal fibers although the loss of myelin occurred also in the patient with ALD (not shown). Consistent with these histological findings, the three AXD patients exhibited elevated levels of HspB5, preferentially in the white matter as visualized by SDS-PAGE/western blotting using the HspB5-specific antibody, compared to the control patients (Fig. 3, lower panel) .
The 8A7 antibody detected HspB5L-P44 in all AXD samples and in the control sample (C1) without neuropathology (Fig. 3, upper panel) . In particular, the sample taken from the gray matter of an AXD patient is distinguished by an elevated amount of HspB5L-P44, whereas the samples derived from white matter, or white matter and cortex combined, contained moderate amounts of this protein comparable to that of the control brain without neuropathology (C1). In contrast, the white matter of the control patient with ALD (C2) did not contain detectable amounts of HspB5L-P44. Of note, all brain samples contained HspB1 as detected by the 8A7 antibody. Fig. 2 Occurrence of HspB5L-P44 in various rat tissues. Purified HspB5 or proteins extracted from rat tissues were separated by SDS-PAGE, followed by western blotting using the 8A7 antibody. The total protein amounts loaded onto the lanes were 0.5 μg purified HspB5, 10 μg eye lens protein, and 30 μg protein from the other tissues. Distinct HspB5L-P44 signals were obtained in the heart, lung, brain, renal cortex, and renal glomeruli, and weak or negligible signals in the other tissues. The numeric values of the ratios of the signal strengths for both proteins (HspB5L-P44: HspB5) are given in parenthesis for each tissue Fig. 3 Occurrence of HspB5L-P44 in human brains. Brain tissues were collected from three patients with AXD with defined missense mutations in the GFAP gene (AXD1, AXD3: R416W; AXD2: R239C), and from one individual each without neuropathology (C1) and with ALD (C2) for control purposes. The western blots were stained with the 8A7 antibody or the HspB5-specific antibody, as indicated. M, matter In summary, HspB5L-P44 can be found also in human tissues as exemplified for the brain. This tentatively suggests that the presence of this protein may be a general feature of many mammalian tissues, although the experimental proof still needs to be provided. Confirming the findings of Fig. 2 , the relative amounts of HspB5L-P44 and HspB5 do not seem to correlate.
Regulation of the formation of HspB5L-P44 in response to oxidative stress in endothelial cells
Using the 8A7 antibody, we detected HspB5L-P44 in cultured rat pulmonary arterial endothelial cells which contain also HspB5. Considering the fact that HspB1 formed covalently bonded dimers in oxidative conditions (Zavialov et al. 1998a ), we exposed the endothelial cells for 30 min to UV light and determined the formation of the HspB5L-P44 in the following recovery period of up to 24 h (Fig. 4) . The formation of HspB5L-P44 was induced in the time period between 1 and 6 h following the exposure to UV light, before returning to normal. In contrast, no major change was seen in the HspB5 band, confirming the above observation according to which the amounts of HspB5L-P44 and HspB5 do not correlate.
We conclude that the formation of HspB5L-P44 is physiologically regulated in live cells. Similarly to HspB1, HspB5 can dimerize in oxidative conditions resulting in the formation of HspB5L-P44.
The exposed position of the 8A7 epitope in spatial models of the α-crystallin domain in HspB5 monomers and dimers When the signal intensities for HspB5L-P44 obtained with both antibodies are compared to the signals obtained for HspB5, it is evident that the 8A7 antibody exhibits a much stronger affinity towards HspB5L-P44 than the HspB5-specific antibody (cf. Figs. 1, 3) . In order to elucidate this antibody behavior, we have mapped the position of the ho-ADP (i) onto a model of the secondary and tertiary structures of the α-crystallin domain of HspB5 and (ii) onto a model of α-crystallin domain dimers of this protein.
Figure 5(a) shows the aligned sequences of rat and human HspB5 containing the ho-ADP sequences for the 8A7 antibody (green), to which the human HspB1-derived 8A7-ADP is also aligned. Being positioned in the most conserved parts of sHSPs (Fontaine et al. 2003; Benndorf et al. 2014) , the ho-ADP (HspB5) and 8A7-ADP (HspB1) sequences differ in just two amino acid residues. This explains both the crossreactivity of the 8A7 antibody with HspB5 (cf. Figs. 1-4 ) and the reduced affinity towards HspB5 monomers, compared to the HspB5-specific antibody (cf. Fig. 3) .
The prevailing secondary structures in the α-crystallin domain of all studied sHSPs are β-strands which typically assemble into two main β-sheets (Mymrikov et al. 2011) . Figure 5 (a) illustrates the positions of the various β-strands along the α-crystallin domain sequence, as derived from the Bworm^-style X-ray structural model of a single α-crystallin domain of human HspB5 that is shown in Fig. 5 (b) (X-ray structure, PDB ID 2WJ7; ref. Bagneris et al. 2009 ). In this model, the ho-ADP extends from the C-terminal end of β-strand 5 through two small β-strands (designated β-strands 5-2 and 6), to reach the N-terminal end of β-strand 7. In this manner, the ho-ADP forms an additional small β-sheet that protrudes into the space outside the core β-sheet structure (in Fig. 5(b) , the ho-ADP segment is labeled green with the single amino acid residues being indicated). Although another model differs slightly (Rajagopal et al. 2015) , both models clearly demonstrate that the ho-ADP sequence in HspB5 is located in an exposed position: By protruding out of the core β-sheet structure of the α-crystallin domain, the ho-ADP segment becomes an easily accessible target for the 8A7 antibody thus facilitating its binding.
This feature, however, does not explain the high affinity of the 8A7 antibody towards HspB5L-P44 relative to monomeric HspB5. The key for understanding must reside in the quaternary structure of HspB5L-P44. Therefore, we labeled the two ho-ADP segments in a model of HspB5 α-crystallin domain dimers as shown in Fig. 5 (c) (solid-state NMR structural model, PDB ID 2KLR; ref. Jehle et al. 2010 ). This space-filling model confirms that both ho-ADPs (labeled green and yellow) keep largely their exposed position also in this dimeric complex. Both ho-ADP segments are in an adjacent position with a distance spanning approximately 1 to 5 nm, which is, however, on the short side of the optimal range for antibody binding through both antigen binding sites that typically occurs at an epitope distance of 6-12 nm (Preiner et al. 2014 ).
Bivalent antibody binding (which is required for high avidity) is a highly complex process, influenced by a number of factors including the flexibility of the antibodies, steric restraints of both antibody and antigen, and other experimental specifics like the polymeric nature and the immobilization of the antigen, with the latter resulting in a high epitope density Fig. 4 Physiological regulation of the HspB5L-P44 in response to UVirradiation in rat pulmonary arterial endothelial cells. Cells grown in 6-well plates were exposed for 30 min to~240 μW/cm 2 UV light in a biological safety cabinet, and were subsequently allowed to recover in an incubator. At the times indicated, the cells were harvested and processed for SDS-PAGE followed by western blotting, using the 8A7 antibody which stained both HspB5L-P44 and HspB5 (Kaufman and Jain 1992) . And even a short distance between the epitopes may enhance bivalent antibody binding, unless steric constraints prevent it (Plückthun and Pack 1997) . Some of these factors may enhance the bivalent antibody binding by several orders of magnitude (Crothers and Metzger 1972; Plückthun and Pack 1997) as demonstrated impressively for the bivalent IgG antibody binding on the surface of a Dengue virus resulting in a 20,000-fold increase over monovalent Fab fragments of the same antibody (Edeling et al. 2014) .
Another factor contributing to antibody binding is the ability of proteins to refold following the immobilization on blotting membranes. Denatured proteins indeed can refold to a large extent when returned into Bphysiological^conditions, and several blotting techniques even rely on the correct refolding of the transferred proteins on blotting membranes (Hall 2004; Franke et al. 2009 ). For urea-and thermally denatured bovine HspB5, it was shown that the secondary, tertiary, and also quaternary structures were largely restored by refolding (Maiti et al. 1988; Raman et al. 1995; Saha and Das 2007) , suggesting that also HspB5L-P44 could be partially refolded on the blots shown in Figs. 1-4 .
In summary, the experimentally observed high avidity of the 8A7 antibody towards HspB5L-P44 can be explained by a number of factors that include (i) the exposed position of the epitope (ho-ADP) as part of the highly ordered β-sheet structure in the α-crystallin domain of HspB5, (ii) the exposed and adjacent position of both epitopes in HspB5 dimers, (iii) experimental specifics such as the immobilization of the antigen, and (iv) the ability of HspB5 and of its derivative protein species to largely refold on the blotting membrane. Together, these factors make a bivalent binding of HspB5L-P44 by the 8A7 antibody plausible, resulting in the observed high avidity.
Qualitative differences between the epitopes for the 8A7 and the HspB5-specific antibodies in the spatial structure of HspB5 dimers
The above considerations, however, do not explain the relatively poor reactivity of the HspB5-specific antibody towards HspB5L-P44. As noted, the weak signal obtained with the HspB5-specific antibody for HspB5L-P44 contrasts with the strong signal obtained with the 8A7 antibody, if set in relation to the signals obtained for monomeric HspB5. This unexpected antibody behavior may also be explained by the structural model of HspB5 α-crystallin domain dimers, taking into account the nature of the C-terminal extensions which carry the epitope for the HspB5-specific antibody, herein termed the anti-HspB5 antigen determinant peptide (aB5-ADP). This antibody was raised against the 13 uttermost C-terminal amino acid residues of human HspB5, constituting approximately half of the C-terminal extension (labeled blue in Fig. 5(a) ) (Bhat et al. 1991 ). These C-terminal extensions are distinguished by their intrinsically disordered and highly flexible nature which has been studied extensively (Carver et al. 1995; Treweek et al. 2010; Sudnitsyna et al. 2012) . This structural characteristic may have negative implications for antibody binding, be it by the intrinsic properties of the C-terminal extensions or by their unpropitious positioning in space.
With regard to the spatial constellation, the C-terminal extensions theoretically can take up any position which is within reach of their length. In an unfolded conformation and with an average length of 0.38 nm for each amino acid residue (Rico et al. 2013) downstream of Lys150 which is the most Cterminal amino acid residue that is covered by the model shown in Fig. 5(c) , all 25 downstream amino acid residues would add up to approximately 9 nm length. This length delineates the maximal radii of the two overlapping spheres, and therein the two aB5-ADP segments theoretically can adopt any position using the two Lys150 residues as Banchor points (  Fig. 5(d) ; Lys150 residues indicated by black dots). According to this model, the distances between both aB5-ADP segments can be estimated to be in the range between (a) Aligned sequences of rat (rHspB5) and human HspB5 (hHspB5) which differ in five positions (highlighted gray). The ADP for the 8A7 antibody (8A7-ADP, derived from human HspB1) is placed below the homologous site of HspB5 (ho-ADP; labeled green in hHspB5). Both the 8A7-ADP and ho-ADP differ in two positions (underlined in the 8A7-ADP sequence). The ADP of the HspB5-specific antibody (aB5-ADP) is composed of the 13 uttermost C-terminal residues of human HspB5 (labeled blue). The positions of the α-crystallin domain and of the Cterminal extension are indicated as defined previously (Fontaine et al. 2003) . The β-strands 2 through 9 are delineated according to the spatial model of the α-crystallin domain of HspB5 as shown in panel b. Lys150, the hindmost C-terminal amino acid residue which is covered by the model shown in panel c, is labeled red. (b) X-ray structure (PDB ID 2WJ7) of the α-crystallin domain of human HspB5 with β-strands 2 to 9 shown as planks. This view features the ho-ADP sequence (green ribbon with the positons of the amino acid residues indicated) which forms a short yet separate β-sheet protruding away from the core β-sheet structure. (c) Space-fill representation of the human HspB5 α-crystallin domain dimer NMR structure (PDB ID 2KLR). The monomers are colored magenta and blue with the corresponding ho-ADP segments green and yellow, respectively. (d) Different quality of the binding sites for both antibodies (ho-ADP vs. aB5-ADP) in the human HspB5 dimer (based on model PDB ID 2KLR). The ho-ADP sites reside in the highly ordered α-crystallin domain, whereas the aB5-ADP sites reside in the extreme end of the disordered and flexible C-terminal extensions which theoretically can move freely in three dimensions within the spherical space delineated by the circles (either in extended or in random coil conformations as indicated), with Lys150 serving as Banchor points^(black dots). HspB5 molecule 1 is colored magenta with both antibody binding sites in green, and HspB5 molecule 2 is colored blue with both antibody binding sites in yellow. To illustrate the size proportion, a stylized antibody is also shown to scale. The measure indicates the range of epitope distances that typically are optimal for bivalent antibody binding (6-12 nm), although with exceptions. In panels c and d, the extreme N-and C-terminal amino acid residues that are included in these models are indicated 0 nm and maximal 25 nm. Both extreme positions, as well as most intermediate positions, would be outside the optimal range for bivalent antibody binding (6-12 nm), contributing to the poor binding of the HspB5-specific antibody towards HspB5L-P44. Even at a permissive distance, a major fraction of these flexible C-terminal extensions can be expected to adopt conformations and/or relative constellations that are unfavorable for antibody binding.
However, in solution, a random coil conformation of the Cterminal extensions is more probable (Fisher et al. 1999) , even though on the blotting membranes the fate of the C-terminal extensions is less certain. In such a random coil conformation, unfolded proteins are best described as Kuhn-type polymers following a random flight model, in which each subsequent amino acid residue is restrained by permissible bond angles only, and the ensemble is statistically distributed (Kuhn 1934; Tanford et al. 1966) . According to this model, the 25 Cterminal residues are expected to be broadly distributed between 0 and 6 nm with a statistical average of approximately 3.5 nm (Goldenberg 2003) . In Fig. 5(d) , this constellation is also visualized by the inner spheres which delineate the average space occupied by the C-terminal extensions in a random coil conformation. Also in this model, a fraction of the possible positions of the aB5-ADP segments would be outside the optimal range for bivalent antibody binding and/or adopt unfavorable spatial conformations and relative constellations, thus attenuating the binding of the HspB5-specific antibody towards HspB5L-P44.
To visualize the size proportions of HspB5L-P44 dimers and of antibodies, a stylized IgG antibody is also shown in Fig. 5(d) .
Taken together, on the blotting membrane, these disordered and flexible C-terminal extensions can be expected to adopt an extended or random coil conformation. In any case, the result for antibody binding towards HspB5L-P44 is similar: The bivalent binding by the HspB5-specific antibody will be attenuated (i) by largely unfavorable epitope-epitope distances in the dimeric structure, and/or (ii) by unfavorable conformations and relative constellations of these extensions. Thus, these structural features of the C-terminal extensions provide a rationale for the observed low affinity of the HspB5-specific antibody (and of similar antibodies) towards HspB5L-P44. This antibody property may also provide an explanation for the fact that the HspB5L-P44 was not noticed in previous studies.
Although Fig. 5(c, d) shows the quaternary structure of an HspB5 α-crystallin domain dimer, this model, however, does not feature the covalent bond between the HspB5 monomers, the existence of which can be postulated on the basis of the electrophoretic behavior as shown in Figs. 1-4 , and which has not been reported before in naturally occurring HspB5 species. Both the exact position and the chemical nature of this postulated covalent bond remain to be determined.
HspB5 speciation as found in proteome databases
The existence of HspB5L-P44 in rat and human tissues, as described in this study, suggests that HspB5 is subjected to protein speciation, similar to HspB1 (Scheler et al. 1997; Benndorf and Jungblut 2015) or other studied proteins (Jungblut et al. 2016) . In order to find further evidence for the speciation of HspB5 in vertebrates, we searched proteomics databases for HspB5 and its derivatives and re-evaluated various two-dimensional gels from earlier published studies.
Among the different proteomics approaches (Schlüter et al. 2009 ), the two-dimensional gel electrophoresis mass spectrometry (2-DE-MS) top-down method is best suited for the identification of putative HspB5 dimers. In particular, this approach has been used to build a number of welldocumented 2D-PAGE databases. Table 1 lists such databases and studies that are based on a total of 11 two-dimensional gel electrophoretic protein patterns from four species (human, rat, mouse, Asiatic toad) and six organs or tissues, with samples containing between one and four spots of HspB5. Comparison of the determined Mr and pI values reveals the existence of at least ten different HspB5 species in these tissues, in spite of the limited comparability of these data between the databases. Since these studies were not designed to identify the complete set of HspB5 species, the true numbers of HspB5 species in these samples can be expected to be even higher. Identified HspB5 spots with a Mr smaller than 20 kDa can be assumed to contain truncated proteins. Peptide mass fingerprints of such lower mass HspB5 spots in the mouse eye lens suggest truncation from both the N-and C-terminal ends of the protein (Hoehenwarter et al. 2008) . In one study of the human heart, an HspB5 form with an estimated Mr of 30 kDa was identified that is clearly above the size of the HspB5 monomer (Polden et al. 2011) . However, identity of this or any other HspB5 species listed in Table 1 with HspB5L-P44 can be excluded, based on the different masses and isoelectric points.
In summary, in vertebrate tissues, a number of noncanonical HspB5 species exist that have been largely neglected in earlier studies. HspB5 shares this speciation with HspB1 and other studied proteins, thus further supporting the concept of the protein code. HspB5L-P44 as reported in this study is just one non-canonical HspB5 species among others.
Discussion
In recent decades, a number of different modifications of HspB5 have been reported, among them phosphorylation at three sites (Ito et al. 1997 (Ito et al. , 2001 den Engelsman et al. 2005) . Other modifications and variations include O-GlcN-acylation (Roquemore et al. 1996) , alternative transcription initiation sites (Macip et al. 1997) , addition of a C3-body to the Cterminal lysine (Lin et al. 1997 ), cross-linking by tissue transglutaminase (Merck et al. 1993 ), carbamylation and acetylation (Lapko et al. 2001 ), C-terminal truncation (Kamei et al. 2000) , glycation (Ortwerth et al. 1992) , ubiquitinylation (Goldman and Corbin 1991) , and others (reviewed in Groenen et al. 1994; Hanson et al. 2000) . The existence of HspB5L-P44, being most likely a naturally occurring covalently bonded HspB5 dimer, further adds to the complex modification pattern of this sHSP, the more so as HspB5L-P44 exists in at least four protein species.
Although HspB5 dimers per se have been known for a long time, notably as building blocks of larger oligomers, all naturally occurring dimers reported to date were formed by association and thus could be dissociated in suitable conditions. A separate finding is the formation of covalently bonded dimers of HspB5 in vitro, together with the closely related HspB4 (αA-crystallin), upon chemical oxidation of the purified proteins (Balasubramanian and Kanwar 2002; Shum et al. 2005) . However, mixed dimers of this type, which formed only in harsh oxidative conditions, do not seem to exist in a physiological environment in tissues, the more so as the expression of the HspB4 gene (CRYAA) is restricted to the eye lens. Nevertheless, the existence of these dimers demonstrates the possibility of HspB5 forming covalently bonded dimers. The putative covalently bonded HspB5 dimers reported here are distinguished by the fact that they occur naturally in a number of mammalian tissues.
The related HspB1 is also subject to numerous modifications that may explain the highly complex HspB1 species patterns (with~60 HspB1 species) found in a few studied experimental systems using suitable analytical tools (Benndorf and Jungblut 2015) . Known modifications of HspB1 include the formation of covalently bonded HspB1 dimers via a sulfur bridge in oxidative conditions (Zavialov et al. 1998a, b) . HspB5, in contrast, has no cysteine in its primary sequence (cf. Fig 5(a) ) thus excluding the involvement of a sulfur bridge in the formation of HspB5L-P44. Instead, HspB5L-P44 must be formed by another bond. A candidate is the dityrosine bond which has been identified in the mixed HspB4/HspB5 dimers that formed upon chemical oxidation in vitro (Balasubramanian and Kanwar 2002; Shum et al. 2005) . Also, HspB8 forms covalently bonded dimers, albeit the nature of this bond is not known (Benndorf et al. 2001) . In summary, the property Bcovalently bonded dimer formation^is shared by some sHSPs including HspB5, HspB1, and HspB8, irrespective of the differing nature of the involved chemical bonds.
The fact that a number of mutations in the CRYAB gene in patients are associated with cataracts in the lens of the eye and/ or with various myopathies including myofibrillar or desminrelated myopathy, dilated cardiomyopathy and hypertonic infantile muscular dystrophy (Datskevich et al. 2012; Benndorf 2010; Benndorf et al. 2014 ) raise the question of the involvement of HspB5L-P44 in these disorders. For example, mutant HspB5 may result in abnormal formation of HspB5L-P44, or in formation of HspB5L-P44 with abnormal properties, eventually contributing to the etiology of these disorders.
As demonstrated in this study, HspB5-specific antibodies raised against epitopes in the C-terminal extensions are poorly suitable to detect HspB5L-P44 species on western blots. This implies the possibility that most if not all studies using this or similar antibodies in the past have missed HspB5L-P44, and potentially missed also important aspects of the regulation and biological function of HspB5 and of its derivatives. The fact that the relative amounts of HspB5L-P44 and HspB5 do not Figs. 2-4 ) indeed suggests such a specific regulation of the HspB5-derived species. Unfortunately, no data on possible functional implications are available at this time.
Using published data on the structural features both of the HspB5 α-crystallin domain dimers and of the intrinsically disordered and flexible C-terminal extensions, we provide an explanation for the surprising difference by which the 8A7 antibody and the HspB5-specific antibody label HspB5L-P44, relative to monomeric HspB5. The relative affinities of the antibodies used in this study towards HspB5L-P44 and HspB5 are not known and may differ by orders of magnitude. This implies that at this time no conclusions can be drawn on the amounts of HspB5L-P44 in these tissues, relative to monomeric HspB5.
The formation of HspB5L-P44 with its four species represents another example of protein speciation ). An additional reason why these protein species were not identified earlier is the limitation of the bottom-up proteomics. As long as not all spots of a 2-DE pattern are investigated by mass spectrometry, 2-DE-MS has to be complemented by two-dimensional immunoblotting to detect the various species of a protein of interest. Such protein species may be regulated in a protein species-specific manner, e.g., during the development of diseases, and functional consequences can be better deduced as compared to the fuzzy data obtained at the protein level by the bottom-up approaches. Hereby the protein speciation discourse directly leads to the protein code concept (Sims and Reinberg 2008; Benndorf and Jungblut 2015; Jungblut et al. 2016) , and HspB5 with all of its derivatives (species), including HspB5L-P44, well suites this picture, even in the absence of known functional consequences.
In conclusion, we provide electrophoretic and immunological evidence for a novel 44-kDa HspB5-related protein we term HspB5L-P44. This protein exists in at least four species and is most likely a covalently bonded HspB5 dimer. With this putative HspB5 dimer occurring in a number of rat tissues and human brains, it can be concluded that it occurs widely in mammalian tissues. The relative amounts of HspB5 and HspB5L-P44 do not correlate in the tested tissues, suggesting a physiological regulation of the formation of HspB5L-P44 independent of HspB5. At present, no data on possible functional implications on HspB5L-P44 are available. The fact that previous studies on HspB5 have missed the HspB5L-P44 species is attributable to (i) the unique properties of the HspB1-/HspB5-specific 8A7 antibody that was used in the present study, but was rarely used in earlier studies, and to (ii) the limitations of bottom-up proteomics. With these newly HspB5-derived species, HspB5 represents another example supporting the concept of the protein code, according to which the expression of genes is reflected only by the complete set of the derived protein species.
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